百时美施贵宝是一家以“研发并提供创新药物,帮助患者战胜严重疾病”为使命的全球领先的生物制药公司,始终践行“引领科学,改变患者生命”的企业愿景。在中国,我们致力于成为“根植中国、源于中国”的创新领导者,专注于加速引进公司在肿瘤学、血液学和免疫学等核心疾病领域的创新药物,早日惠及中国患者。
Bristol Myers Squibb is a global leading biopharmaceutical company with a mission to “discover, develop and deliver innovative medicines that help patients prevail serious diseases”. At Bristol Myers Squibb, we are inspired by a single vision – transforming patients’ lives through science. We are committed to accelerating innovative medicines in core therapeutic areas, such as oncology, hematology and immunology to benefit patients in China. Our innovative portfolio is strong, and we aim to become an innovation leader in China and from China.